CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Calquence Shows Favorable Long-Term Outcomes in Treatment-Naive Chronic Lymphocytic Leukemia

June 4th 2020

“Collectively, these results support acalabrutinib (Calquence) use in upfront CLL,” said Dr. John C. Byrd. “This is compounded and supported by two additional phase III studies that have been completed with this agent.”

Novel Combination Therapy Shows Exciting Results in Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma

June 3rd 2020

Results from an early-phase trial showed that cirmtuzumab plus Imbruvica is safe and efficacious in treating patients with relapsed/refractory MCL and CLL.

Infection Risks, Impact of COVID-19 in Stem Cell Transplants for Blood Cancers

May 12th 2020

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients,” Dr. Farukh Awan addressed concerns about the possibility of developing COVID-19 or any infection after a stem cell transplant to treat a blood cancer.

Blood Cancer Therapies May Play a Role in Treating COVID-19

May 7th 2020

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients,” Drs. Zainab Shahid, Farukh Awan and Ian Flinn addressed clinical trials that are underway to assess therapeutic approaches to COVID-19, including what role BTK inhibitors might play in treating the virus.

One Cancer Organization's Observations on the Impact of COVID-19 on the Blood Cancer Community

May 6th 2020

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients”, Dr. Lee Greenberger addresses steps that the Leukemia and Lymphoma Society have taken to help patients with blood cancer during the COVID-19 pandemic.

How Patients With Blood Cancers Can Boost Immune Systems to Fight Infections Like COVID-19

May 6th 2020

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients,” Drs. Ian Flinn and Farrukh Awan addressed what patients with blood cancers could do to help boost their immune systems to help prevent infections such as COVID-19, and the risk for patients who are several years removed from receiving a stem cell transplant.

Chronic Lymphocytic Leukemia

May 6th 2020

Understanding chronic lymphocytic leukemia.

COVID-19's Impact on CLL, Myeloma Clinical Trials

May 5th 2020

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients”, Dr. Ian Flinn and Dr. Saad Usmani how the new coronavirus has affected stem cell transplantations as well as the management of chronic lymphocytic leukemia and myeloma clinical trials.

DKMS Donates 12,000 Buccal Swabs to Memorial Sloan Kettering for COVID-19 Testing

May 5th 2020

International Nonprofit Provides 126K+ Swabs Globally to Help Fight Virus

COVID-19's Impact on How Patients with CLL, Myeloma Have Received Treatment

May 4th 2020

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients”, Dr. Farukh Awan addresses how the new coronavirus has impacted patient care for those diagnosed with chronic lymphocytic leukemia and myeloma.

How Patients with Chronic Lymphocytic Leukemia Are Equipped to Handle the COVID-19 Pandemic

May 4th 2020

Patients with chronic lymphocytic leukemia are at risk for the worst of COVID-19 symptoms, but going on the cancer journey has prepared them for the pandemic.

How Social Distancing Helped Create a Sense of Community Among Some Patients with CLL

May 1st 2020

Social distancing measures are keeping people apart, but that hasn't stopped some patients with CLL from finding a new sense of community.

How COVID-19 Has Impacted Clinical Trials for Chronic Lymphocytic Leukemia

April 30th 2020

The COVID-19 Pandemic has changed immediate treatment for patients with chronic lymphocytic leukemia, but it is also impacting the clinical trials looking to improve the future treatment for these patients.

5 Cancer-Related FDA Approvals Patients May Have Missed

April 27th 2020

Dr. Richard Pazdur, director of the Food and Drug Administration’s Oncology Center of Excellence, has noted that the agency is committed to expediting oncology drug development despite the challenges posed by the COVID-19 pandemic.

FDA Approves Imbruvica, Rituxan Combination in Previously Untreated Patients with CLL and SLL

April 21st 2020

The Food and Drug Administration, under its global Project Orbis, approved the combination of Imbruvica and Rituxan for patients with CLL and SLL.

Calquence Could Offer Treatment for Chronic Lymphocytic Leukemia with Fewer Side Effects

April 20th 2020

Calquence (acalabrutinib) may be a safe and effective treatment option for patients with relapsed or refractory chronic lymphocytic leukemia, according to the updated phase 2 results of an ongoing study.

New Prognostic Tool Helps Patients With Leukemia Anticipate Care Needs

April 17th 2020

First validated prognostic score offers valuable insights for patients with chronic lymphocytic leukemia who are prescribed active surveillance.

Treatment Advances in Chronic Lymphocytic Leukemia

April 8th 2020

Bruton tyrosine kinase (BTK) inhibitors and other new drugs are improving outcomes for patients with CLL.

How COVID-19 is Impacting Patients with Chronic Lymphocytic Leukemia

April 1st 2020

The COVID-19 pandemic's impact is being felt all throughout the cancer community, and experts from the CLL Society hosted a webinar to discuss the specific impacts of the pandemic on patients with chronic lymphocytic leukemia.

Chimeric Antigen Receptor-Natural Killer Cells Shows Promise in CLL, Non-Hodgkin Lymphoma

March 21st 2020

Patients with relapsed or refractory CD19-positive cancers experienced complete responses with no major side effects following treatment with CAR-NK cell therapy.

Transitioning to Targeted Treatment for Patients with CLL Using BTK Inhibitors

March 3rd 2020

Newer medications that displace chemotherapy aim directly at mutations in the Bruton tyrosine kinase gene and help patients with CLL live longer.

Reliable Information and Advice for Patients With CLL

February 21st 2020

Chronic Lymphocytic Leukemia: Patient Support and Communication

February 21st 2020

Chronic Lymphocytic Leukemia: What Happens at Progression?

February 21st 2020

Considerations for CLL as an Enduring Disease

February 21st 2020

Chemotherapy-Free Therapy for CLL: Communication and Adherence

February 21st 2020

Addressing Physical and Emotional Fatigue in CLL

February 21st 2020

CLL: Experience With Chemotherapy-Free Treatment

February 21st 2020

Nathan's Story: Choosing Chemotherapy-Free Therapy for CLL

February 21st 2020

The Treatment Landscape of Chronic Lymphocytic Leukemia

February 21st 2020